Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate report finds Medicare fraud tied to improper code use

This article was originally published in The Gray Sheet

Executive Summary

Questionable diagnostic codes were used in millions of Medicare claims totaling over $1 billion, according to a review of CMS data from 1995 to 2006 outlined in a Sept. 24 report by Republicans on the Senate Homeland Security investigations subcommittee. CMS "does not review the claims to determine whether the diagnoses are remotely related to the purchased medical equipment," according to the report, entitled "Medicare Vulnerabilities: The Use of Diagnosis Codes in DME [durable medical equipment] Claims." For example, the subcommittee found "hundreds of thousands of claims" for blood glucose test strips with corresponding diagnoses of chronic airway obstruction, bubonic plague, leprosy, typhoid or cholera instead of diabetes. The report recommends CMS strengthen its review process and contractor oversight, link diagnosis codes with medical procedures and link claims for DME items with claims for medical treatment

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel